Published 17 Aug 2021

Qure.ai secures FDA clearance for qER-Quant

SHARE

https://cms.qure.ai
Qure.ai, a prominent AI software developer, has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting 510(k) clearance for its advanced head CT quantification software, qER-Quant.
This innovative technology has been carefully engineered to assess the severity of injuries in patients diagnosed with traumatic brain injury, hemorrhagic stroke, and hydrocephalus.
Notably, the qER-Quant is a diagnostic tool and an instrument for tracking pathology progression over time, enhancing the scope for personalized care. The FDA approval confirms the software's reliability, opening up new possibilities for AI-assisted diagnostics in the rapidly evolving healthcare landscape. 

Share this story

Featured in

image 30.svg
image 26.svg
livemint logo.svg
image 29.svg
image 28.svg
image 31.svg
image 27.svg
image 30.svg
image 26.svg
livemint logo.svg
image 29.svg
image 28.svg
image 31.svg
image 27.svg